David Ly Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6800 Skyway, Paradise, CA 95969 Phone: 530-876-0186 |
Hardeep Singh Dhadli Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6020 Clark Rd, Paradise, CA 95969 Phone: 530-877-7001 Fax: 530-877-2740 |
Mr. Thomas Robert Jacobsen, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5974 Pentz Rd, Paradise, CA 95969 Phone: 530-877-9361 Fax: 530-876-7935 |
Janet Liang, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6020 Clark Rd, Paradise, CA 95969 Phone: 530-877-7001 |
News Archive
The Icahn School of Medicine at Mount Sinai today announced the publication of two papers in the journal Nature that reveal new information about the genetic complexity underpinning schizophrenia. These collaborative studies represent the largest exome sequencing efforts to date to elucidate this mental illness, and together found that the disorder is likely caused by far more rare genetic mutations than previously suspected.
Loyola University Health System will celebrate Nurses Week from May 2 - 6. This event takes place each year just prior to May 12, the birthday of Florence Nightingale, the founder of modern nursing. The theme for the week, "Nurses Trusted to Care," reflects the confidence patients place in the hands of nurses.
In related news, Politico Pro reports that five leading health systems announced a plan to partner in sharing electronic health records. These systems note that the ability to share patient data with EHRs is key to success in creating ACOs.
Kaiser Foundation Hospitals - Kaiser Sunnyside Medical Center, Kaiser Foundation Health Plan of the Northwest and Northwest Permanente P.C., Physicians & Surgeons (collectively, Kaiser NW) has agreed to pay the United States $1,830,322.41 to settle False Claims Act liability, the Justice Department announced today.
Optimer Pharmaceuticals, Inc. today announced the pricing of a previously announced underwritten public offering of 6,000,000 shares of its common stock, offered at a price to the public of $11.25 per share. The gross proceeds to Optimer from this offering are expected to be $67.5 million, before deducting the underwriting discounts and commissions and other estimated offering expenses payable by Optimer.
› Verified 9 days ago